GT
GMED icon

Greenleaf Trust’s Globus Medical GMED Stock Holding History

Greenleaf Trust’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Sell
3,810
-47
-1% -$4K ﹤0.01% 696
2026
Q1 		$332K Buy
3,857
+27
+0.7% +$2.42K ﹤0.01% 617
2025
Q4 		$334K Buy
3,830
+11
+0.3% +$835 ﹤0.01% 613
2025
Q3 		$219K Sell
3,819
-622
-14% -$35.8K ﹤0.01% 755
2025
Q2 		$262K Sell
4,441
-151
-3% -$9.76K ﹤0.01% 678
2025
Q1 		$336K Sell
4,592
-6
-0.1% -$496 ﹤0.01% 608
2024
Q4 		$380K Sell
4,598
-48
-1% -$3.79K ﹤0.01% 579
2024
Q3 		$332K Buy
4,646
+61
+1% +$4.31K ﹤0.01% 630
2024
Q2 		$314K Buy
4,585
+23
+0.5% +$1.37K ﹤0.01% 608
2024
Q1 		$245K Sell
4,562
-91
-2% -$4.89K ﹤0.01% 677
2023
Q4 		$248K Buy
+4,653
New +$227K ﹤0.01% 649

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Greenleaf Trust's GMED Position: Q2 2026 in Review

Greenleaf Trust reduced its Globus Medical (GMED) stake by 1.2% in Q2 2026, selling an estimated $4K and leaving 3,810 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Greenleaf Trust first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $380K in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Greenleaf Trust held 3,810 shares of Globus Medical worth $301K as of Q2 2026.
  • Greenleaf Trust sold 47 Globus Medical shares in Q2 2026, an estimated $4K.
  • Globus Medical made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #696 holding.
  • Greenleaf Trust first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
  • Greenleaf Trust's Globus Medical position peaked at $380K in Q4 2024.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.